IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $184,028,311 | +34.5% | 4,677,893 | -16.8% | 0.01% | +25.0% |
| Q1 2023 | $136,836,251 | -49.6% | 5,624,178 | -55.6% | 0.01% | 0.0% |
| Q4 2022 | $271,343,318 | +142.2% | 12,673,672 | +103.0% | 0.01% | +14.3% |
| Q3 2022 | $112,024,000 | +33.3% | 6,244,356 | -28.5% | 0.01% | +40.0% |
| Q2 2022 | $84,017,000 | -15.2% | 8,733,590 | +48.3% | 0.01% | 0.0% |
| Q1 2022 | $99,126,000 | +2.5% | 5,889,843 | +1.8% | 0.01% | 0.0% |
| Q4 2021 | $96,728,000 | +25.7% | 5,785,151 | +22.1% | 0.01% | +25.0% |
| Q3 2021 | $76,969,000 | +280.5% | 4,739,458 | +47.8% | 0.00% | +300.0% |
| Q2 2021 | $20,228,000 | -11.4% | 3,205,626 | -13.2% | 0.00% | 0.0% |
| Q1 2021 | $22,835,000 | -3.2% | 3,694,983 | +8.2% | 0.00% | 0.0% |
| Q4 2020 | $23,600,000 | +259.0% | 3,415,272 | +193.1% | 0.00% | – |
| Q3 2020 | $6,573,000 | +73.9% | 1,165,414 | +57.3% | 0.00% | – |
| Q2 2020 | $3,779,000 | +7940.4% | 741,035 | +1679.1% | 0.00% | – |
| Q3 2019 | $47,000 | -13.0% | 41,652 | 0.0% | 0.00% | – |
| Q2 2019 | $54,000 | – | 41,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |